Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms

被引:169
作者
Sreevatsan, S
Pan, X
Zhang, Y
Kreiswirth, BN
Musser, JM
机构
[1] BAYLOR COLL MED, DEPT PATHOL, SECT MOL PATHOBIOL, HOUSTON, TX 77030 USA
[2] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT MICROBIOL & IMMUNOL, BALTIMORE, MD 21205 USA
[3] PUBL HLTH RES INST, TB LAB, NEW YORK, NY 10016 USA
关键词
D O I
10.1128/AAC.41.3.636
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A gene (pncA) with mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis complex members was characterized in 67 pyrazinamide-resistant and 51 pyrazinamide-susceptible isolates recovered from diverse geographic localities and anatomic sites and typed by IS6110 profiling, All pyrazinamide-susceptible organisms had identical pncA alleles, In striking contrast, 72% of the 67 resistant organisms had pncA mutations that altered the primary amino acid sequence of pyrazinamidase. A total of 17 previously undescribed mutations were found, including upstream mutations, missense changes, nucleotide insertions and deletions, and termination mutations, The mutations were arrayed along virtually the entire length of the gene, These data are further evidence that most drug resistance in M. tuberculosis is due to simple mutations occurring in chromosomally encoded genes rather than to acquisition of resistance genes by horizontal transfer events.
引用
收藏
页码:636 / 640
页数:5
相关论文
共 34 条
[1]   Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family [J].
Bifani, PJ ;
Plikaytis, BB ;
Kapur, V ;
Stockbauer, K ;
Pan, X ;
Lutfey, ML ;
Moghazeh, SL ;
Eisner, W ;
Daniel, TM ;
Kaplan, MH ;
Crawford, JT ;
Musser, JM ;
Kreiswirth, BN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (06) :452-457
[2]   MUTATION POSITION AND TYPE OF SUBSTITUTION IN THE BETA-SUBUNIT OF THE RNA-POLYMERASE INFLUENCE IN-VITRO ACTIVITY OF RIFAMYCINS IN RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS [J].
BODMER, T ;
ZURCHER, G ;
IMBODEN, P ;
TELENTI, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (02) :345-348
[3]   IMPROVED METHOD FOR TESTING SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS TO PYRAZINAMIDE [J].
BUTLER, WR ;
KILBURN, JO .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 16 (06) :1106-1109
[4]   Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City [J].
Cooksey, RC ;
Morlock, GP ;
McQueen, A ;
Glickman, SE ;
Crawford, JT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1186-1188
[5]   AMPLIFICATION OF A SPECIES-SPECIFIC DNA FRAGMENT OF MYCOBACTERIUM-TUBERCULOSIS AND ITS POSSIBLE USE IN DIAGNOSIS [J].
DELPORTILLO, P ;
MURILLO, LA ;
PATARROYO, ME .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (10) :2163-2168
[6]  
DICKINSON J M, 1970, Tubercle, V51, P389
[7]   PYRAZINAMIDE STERILIZING ACTIVITY INVITRO AGAINST SEMIDORMANT MYCOBACTERIUM-TUBERCULOSIS BACTERIAL-POPULATIONS [J].
HEIFETS, L ;
LINDHOLMLEVY, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (05) :1223-1225
[8]  
Heifets Leonid B., 1994, P85
[9]   DRUG-RESISTANT TUBERCULOSIS - INCONSISTENT RESULTS OF PYRAZINAMIDE SUSCEPTIBILITY TESTING [J].
HEWLETT, D ;
HORN, DL ;
ALFALLA, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :916-917
[10]  
KAPUR V, 1995, ARCH PATHOL LAB MED, V119, P131